Patent Assignment
Reel/Frame 029103/0465
Assignment of Assignor's Interest
Recorded: 2012-10-10
Pages: 85
Assignor
ELAN PHARMA INTERNATIONAL LIMITED
Executed: 2011-08-02
Assignee
EDT PHARMA HOLDINGS LIMITED
MONKSLAND, ATHLONE, COUNTY WESTMEATH, IRELAND
Covered Properties
(18)
Apparatus for Sanitary Wet Milling
Solid Dose Nanoparticulate Compositions Comprising a Synergistic Combination of a Polymeric Surface Stabilizer and Dioctyl Sodium Sulfosuccinate
System and Method for Milling Materials
Compositions Having a Combination of Immediate Release and Controlled Release Characteristics
In Vitro Methods for Evaluating the in Vivo Effectiveness of Dosage Forms of Microparticulate or Nanoparticulate Active Agent Compositions
Nanoparticulate Compositions Comprising Copolymers of Vinyl Pyrrolidone and Vinyl Acetate as Surface Stabilizers
Nanoparticulate Compositions Having Lysozyme as a Surface Stabilizer
Nanoparticulate Polycosanol Formulations & Novel Polycosanol Combinations
Gel Stabilized Nanoparticulate Active Agent Compositions
System and Method for Milling Materials
Nanoparticulate Topiramate Formulations
Sterilization of Dispersions of Nanoparticulate Active Agents with Gamma Radiation
Nanoparticulate Compositions Having a Peptide as a Surface Stabilizer
Methods of Making Nanoparticulate Drug Compositions Comprising Copolymers of Vinyl Pyrrolidone and Vinyl Acetate as Surface Stabilizers
Nanoparticulate Compositions of Mitogen-Activated Protein (Map) Kinase Inhibitors
Nanoparticulate Bisphosphonate Compositions
In Vitro Methods for Evaluating the in Vivo Effectivness of Dosage Forms of Microparticulate or Nanoparticulate Active Agent Compositions
System and Method for Milling Materials
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Patent Security Agreement (Second Lien)
Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0245 →
Patent Security Agreement (First Lien)
Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0186 →
Asset Transfer Agreement
Jun 20, 2012
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 028415/0333 →
Change of Name
Jun 20, 2012
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 028414/0111 →
Change of Name
Oct 10, 2012
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 029103/0695 →
Release by Secured Party (Second Lien)
Oct 12, 2012
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
Reel/Frame 029116/0379 →
Property Transfer Agreement
Aug 6, 2014
From: ALKERMES PHARMA IRELAND LIMITED
To: ALKERMES SCIENCE ONE LIMITED
Reel/Frame 033483/0891 →
Property Transfer Agreement
Aug 12, 2014
From: ALKERMES PHARMA IRELAND LIMITED
To: ALKERMES SCIENCE ONE LIMITED
Reel/Frame 033522/0048 →
Change of Name
Mar 27, 2015
From: ALKERMES SCIENCE ONE LIMITED
To: DARAVITA LIMITED
Reel/Frame 035279/0701 →
Asset Transfer and License Agreement
Apr 10, 2015
From: ALKERMES PHARMA IRELAND LIMITED
To: DV TECHNOLOGY LLC
Reel/Frame 035410/0001 →
Business Transfer Agreement
Apr 10, 2015
From: DARAVITA LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 035409/0831 →
Security Interest
Apr 14, 2015
From: RECRO TECHNOLOGY LLC
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 035403/0288 →
Change of Name
Apr 16, 2015
From: DV TECHNOLOGY LLC
To: RECRO TECHNOLOGY LLC
Reel/Frame 035446/0904 →
Release of Security Interest
Apr 27, 2015
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: DARAVITA LIMITED (F/K/A ALKERMES SCIENCE ONE LIMITED, SUCCESSOR IN INTEREST TO ALKERMES PHARMA IRELAND LIMITED)
Reel/Frame 035505/0696 →
Assignment of Assignor's Interest
Jul 21, 2017
From: RECRO GAINESVILLE LLC
To: RECRO PHARMA, INC.
Reel/Frame 043067/0111 →
Merger
Jul 21, 2017
From: RECRO TECHNOLOGY LLC
To: RECRO GAINESVILLE LLC
Reel/Frame 043060/0408 →
Merger
Sep 13, 2017
From: RECRO TECHNOLOGY LLC
To: RECRO GAINESVILLE LLC
Reel/Frame 043572/0583 →
Security Interest
Nov 17, 2017
From: RECRO GAINESVILLE LLC
To: ATHYRIUM OPPORTUNITIES III ACQUSITION LP
Reel/Frame 044165/0783 →
Release of Security Interest
Nov 17, 2017
From: ORBIMED ROYALTY OPPORTUNITIES II, LP
To: RECRO GAINESVILLE LLC (F/K/A RECRO TECHNOLOGY LLC)
Reel/Frame 044164/0008 →
Corrective Assignment to Correct the Receiving Party's Name Previously Recorded at Reel: 044165 Frame: 0783. Assignor(S) Hereby Confirms the Grant of Security Interest .
Mar 8, 2019
From: RECRO GAINESVILLE LLC
To: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
Reel/Frame 048540/0737 →
Assignment of Assignor's Interest
Jan 30, 2020
From: RECRO PHARMA, INC.
To: BAUDAX BIO, INC.
Reel/Frame 051671/0536 →
Assignment of Assignor's Interest
Feb 14, 2020
From: RECRO GAINESVILLE LLC
To: BAUDAX BIO, INC.
Reel/Frame 051826/0131 →
Security Interest
Jun 10, 2020
From: BAUDAX BIO N.A. LLC; BAUDAX BIO LIMITED; BAUDAX BIO, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 052891/0590 →
Release of Security Interest
Dec 16, 2022
From: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
To: SOCIETAL CDMO GAINESVILLE, LLC
Reel/Frame 062123/0339 →
Partial Release of Intellectual Property Security Agreement
Mar 29, 2023
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: BAUDAX BIO, INC.; BAUDAX BIO N.A. LLC; BAUDAX BIO LIMITED
Reel/Frame 063189/0142 →